Spero Therapeutics, Inc. (SPRO)
2.74
-0.06
(-2.14%)
USD |
NASDAQ |
Apr 24, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Spero Therapeutics Market Cap : 158.62M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SIGA Technologies, Inc. | 327.41M |
| SELLAS Life Sciences Group, Inc. | 800.94M |
| Nephros, Inc. | 30.55M |
| ACADIA Pharmaceuticals, Inc. | 3.744B |
| Alnylam Pharmaceuticals, Inc. | 40.52B |
Market Cap Related Metrics
| PE Ratio | 23.03 |
| PS Ratio | 2.609 |
| Price to Book Value | 2.688 |
| Price | 2.74 |
| Earnings Yield | 4.34% |
| Normalized PE Ratio | 21.14 |